Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.
Wilson AM, Shin DS, Weatherby C et al.
Wilson AM, Shin DS, Weatherby C et al.
Stanford University Medical Center, Stanford, CA, USA.
Vasc Med 2010;15:267–74.
Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.
» Read an expert review of this paper